Search for Clinical Trial Results
ANCA-associated Vasculitis - 103 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy Condition: Invasive Pneumococcal Infection Date: 2017-02-27 Interventions:
|
Not yet recruiting |
Study Name: Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study Condition:
Date: 2012-04-25 Interventions: Other: Observational Observational study of subjects previously enrolled in the RAVE trial |
Active, not recruiting |
Study Name: Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis Condition:
Date: 2014-06-19 Interventions:
|
Completed |
Study Name: Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides Condition:
Date: 2015-06-10 Interventions: Other: blood specimen blood specimen for serum rituximab level and serum anti-rituximab level at M1 and |
Active, not recruiting |
Study Name: Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis Condition:
|
Terminated |
Study Name: The Clinical Efficacy of DFPP in Patients With AAGN Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Date: 2014-06-03 Interventions:
|
Completed |
Study Name: MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis Condition:
Date: 2006-03-10 Interventions: Drug: mycophenolate mofetil MMF,1.0g/d Other Name: M |
Withdrawn |
Study Name: Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Date: 2010-12-13 Interventions:
|
Withdrawn |
Study Name: Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Date: 2011-01-10 Interventions:
|